Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.

But this has yet to help how marijuana stocks perform. There has been a volatile downturn for some time, and even with the progress of business pot stocks won’t move up. Now, with this success for legal operators around the globe, it gives hope for those who want to enter the sector. For instance, watching how an MSO powerhouse like Trulieve can make all this money but trade poorly. Yet even with the market down, the success outside of the public sector keeps positive speculation going. Many feel this is the time to find top marijuana stocks to buy.

People feel the future is where the gains will be made. A classic buy-and-hold long-term strategy is what many are feeling will be the better option. When federal reform matters are met, it has the potential to bring the trading up in a major way. Many are keeping watch for any volatile pops o trading to take profits until the big payday occurs. Below are several marijuana stocks to watch today.

Marijuana Stocks For Investors Who Like Legal Cannabis 2025

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Canopy Growth Corporation (NASDAQ:CGC)
3. Cronos Group Inc.(NASDAQ:CRON)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. 

The company recently announced that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours. This product is a new line of cannabis beverages and gummies that redefine the sour experience.

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Recently, the company announced it will release its Q1 2025 financial results on May 30th. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Judy Hong, CFO.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. Back on May 8th, the company reported its Q1 2025 earnings.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

2025 Highlights And Key Mentions

• Net revenue of $32.3 million in Q1 2025 increased by $7.0 million from Q1 2024.
• Gross profit of $13.7 million in Q1 2025 increased by $9.3 million from Q1 2024.
• Adjusted Gross Profit of $14.3 million in Q1 2025 increased by $9.8 million from Q1 2024.
• Net income of $7.7 million in Q1 2025 increased by $10.2 million from Q1 2024.

The post Top Marijuana Stocks In A Volatile Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stock investors are at the mercy of not just the market but the politics of the entire industry. What this means is that with no federal reform and a lack of regulatory matters met the public sector for cannabis stocks is at all-time lows. Right now, if you are interested in cannabis, you can buy marijuana stocks to buy at lower-than-normal share prices.

Now, many are waiting patiently, and many have grown in frustration. For instance, how can businesses be booming for legal operators, and none of that success has led to better trading? At one point in time, when legal operators did well, so did the market. But that is not the case, and many have been taking profits as they can when they can catch a volatile pop in trading. Now for some time, any upward trading has been short-lived making it nearly impossible to see any gains.

Yet, with how well the cannabis industry as a whole is doing, future gains keep people optimistic. Right now is more of and buy-and-hold time, where shares are so low that this strategy could be profitable. It’s all about patience, strategizing, and choosing the right cannabis stocks to invest in. Below are a few marijuana stocks to watch that could be among the few to see momentum increase.

Marijuana Stocks To Keep On Your Radar

1. Greenlane Holdings, Inc. (NASDAQ:GNLN)
2. Jushi Holdings Inc. (OTC:JUSH)

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. engages in the development and distribution of cannabis accessories, vape devices, and lifestyle products in the United States, Canada, Europe, and Latin America. It has been some time since the company has reported any new updates.

But on March 25th, the company announced it would join the Mainstem B2B procurement marketplace platform. MainStem offers an end-to-end, enterprise-level supply chain solution designed to streamline procurement for the legal cannabis industry.

[Read More] These Cannabis Stocks Could Pay Off Big In The Future

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. On May 8th, the company reported its first quarter of 2025.

[Read More] 3 Marijuana Stocks For Cannabis Real Estate Investors

First Quarter 2025 Financial Highlights

• Total revenue of $63.8 million
• Gross profit and gross profit margin of $25.8 million and 40.4%, respectively
• Net loss of $17.0 million
• Adjusted EBITDA1 and Adjusted EBITDA margin1 of $9.8 million and 15.4%, respectively
• Cash, cash equivalents, and restricted cash of $27.9 million as of quarter end
• Net cash flows provided by operations of $7.5 million

The post 2 Marijuana Stocks That Could Make You Money In 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Is it safe to invest in marijuana stocks with the entire sector trading at all-time lows? If the legal market is profitable and companies are performing well, why are the top marijuana stocks not trading? These are just some of the questions that plague investors and shareholders. The answer is not so simple, which can make things a bit more complex to understand. Although legal cannabis as a business is thriving and growing in all areas, this has not translated to the public sector so well.

Some feel that it’s like walking on a razor blade without better laws in place on the federal level. There is still much fear of what could happen without federal reform or even SAFE Banking in an industry generating billions of dollars. Legal cannabis has come such a long way that it is just a matter of when. But without it in place, it has hurt the confidence of many investors.

Now, what other areas of cannabis investing could be good are companies that do not solely deal directly with the plant. The ancillary side of cannabis could be a potential haven for better profits at this time. With all things, nothing is a guarantee, and with proper planning, you could see a return. The marijuana stocks to watch below are companies that are in cannabis but do not rely only on the industry to be successful.

Top Ancillary Marijuana Stocks For You

1. Innovative Industrial Properties, Inc. (NYSE:IIPR)
2. NewLake Capital Partners, Inc. (OTC:NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership, and management of specialized properties.

Particularly properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Recently, the company reported its Q1 2025 earnings.

Highlights Key Mentions

• Innovative Industrial Properties Inc reported total revenues of $71.7 million and adjusted funds from operations (AFFO) of $55.3 million for the first quarter of 2025.
• The company ended the period with over $220 million in total liquidity, showcasing a strong financial position.
• IIPR successfully acquired a $7.8 million industrial facility in Maryland and executed two new leases totaling 211,000 square feet.

NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally managed real estate investment trust that provides real estate capital to state-licensed cannabis operators.

This is done through a sale-leaseback transaction, third-party purchases, and funding for build-to-suit projects. On May 7th, the company reported its 2025 first quarter results.

First Quarter 2025 Financial and Operational Highlights

• Revenue totaled $13.2 million.
• Net income attributable to common stockholders totaled $6.3 million.
• Funds From Operations (“FFO”)(2) totaled $10.3 million.
• Adjusted Funds From Operations (“AFFO”)(2) totaled $10.7 million.
• Declared a first quarter dividend of $0.43 per common share, equivalent to an annualized dividend of $1.72 per common share.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial mortgage real estate investment trust in the United States.

The company engages in originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. In more recent news, the company has reported its Q1 2025 financial results.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

First Quarter 2025 Financial Highlights

• Net interest income of approximately $13.0 million as of March 31, 2025.
• Total expenses of approximately $4.1 million before provision for current expected credit losses, representing a sequential decrease of approximately 28.3%.
• Net Income of approximately $10.0 million, or $0.47 per weighted average diluted common share, representing a sequential increase of 20.5% on a per share basis.

The post 3 Marijuana Stocks For Cannabis Real Estate Investors appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the opening of a new Trulieve-branded dispensary in Lorain, Ohio. Harvest Grows LLC will operate the dispensary under the Trulieve brand through a licensing agreement with the Company.

The new Trulieve-branded dispensary, located at 7420 Oak Point Road, will be open 9 a.m. – 9 p.m., seven days a week, offering walk-in and express pickup service. The dispensary will host a grand opening celebration Friday, May 16, featuring specials and promotional giveaways.

“We are thrilled to open this new dispensary under our licensing agreement with Trulieve,” said Harvest’s Chief Executive Officer, Mark Eiland. “We are proud to be associated with the Trulieve brand and look forward to serving customers at this new location.”

“Harvest Grows is leveraging the Trulieve brand because they know our reputation for quality, value, and exceptional customer service,” said Trulieve’s Chief Executive Officer Kim Rivers. “We wish them all the best in operating their new dispensary.”

The new dispensary, located at 7420 Oak Point Road, will be open 9 a.m. – 9 p.m., seven days a week, offering walk-in and express pickup service. Trulieve operates owned dispensaries at the following locations in Ohio:

4370 Tonawanda Trail, Beavercreek

2950 N. High Street, Columbus

601 S. High Street, Columbus

8295 Sancus Blvd, Westerville

3674 Maple Avenue, Zanesville

Trulieve dispensaries offer customers a wide assortment of cannabis products featuring popular brands and accessible form factors including capsules, edibles, flower, tinctures and topicals. For more information on store activations and locations in Ohio, please visit https://www.trulieve.com/dispensaries/ohio.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck, APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-branded-dispensary-to-open-in-lorain-ohio-302454592.html

SOURCE Trulieve Cannabis Corp.

The post Trulieve Cannabis Corp. (TCNNF) Dispensary to Open in Lorain, Ohio appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF),  (“Charlotte’s Web” or the “Company”), a botanical wellness innovation company, today announced results for the quarter ended March 31, 2025, reporting its first year-over-year revenue increase in more than three years, building on the sequential quarterly growth trend achieved in 2024.

“Following three sequential quarters of improvement in 2024, Q1 delivered our first year-over-year revenue growth since 2021 – validating the transformation we initiated 18 months ago,” said Bill Morachnick, Chief Executive Officer. “Our upgraded e-commerce platform is converting more visitors, and new digital storefronts on Amazon, TikTok Shop, and Faire are widening our reach. An upcoming nationwide rollout with Whole Foods Market will strengthen our retail footprint. Operationally, we commenced initial in–house gummy production and, as part of our disciplined cost agenda, we mutually concluded our promotional rights agreement with MLB and associated costs. Coupled with robust innovation – including cannabinoid isolates and our new functional mushroom gummy line – we believe these initiatives position the Company to deliver top and bottom-line growth for 2025 and beyond.”

Erika Lind, Chief Financial Officer, added, “Our reengineered cost structure is now flowing through the P&L. Building on the positive traction from the prior quarters, we are structuring for further improvements in cost efficiency and cash flow. As a part of this effort, we have concluded some high-cost promotional sports agreements, thereby eliminating sizeable future cash outlays of more than $18 million over the next three years. This supports near-term cash flow and preserves long-term cash for further investment in innovation. Combined with our transitioning to in-house manufacturing and disciplined SG&A control, we anticipate further improvements to cash flow in 2025.”

First Quarter Business Review

Expansion of Mushroom Wellness Gummy Innovations
Following the successful Q4 2024 launch of its functional mushroom gummies targeting focus, stress, and energy, Charlotte’s Web will continue expanding its botanical wellness portfolio in 2025. The Company’s strategic diversification beyond CBD is gaining market traction with mushroom wellness products now available through multiple distribution channels, including Walmart.com, Amazon.com, and the Company’s direct-to-consumer platform.

E-Commerce Growth and Omnichannel Expansion
Building on the sequential gains recorded in 2024, Charlotte’s Web’s digital channels delivered year-over-year growth in Q1 2025. Order volume growth, stabilized average order values, new subscriber increases, and lower churn rates drove meaningful digital revenue growth and underscored brand loyalty. This performance reflects the past year’s technology and go-to-market enhancements: a unified brand architecture, an expanded product portfolio, data-driven segmentation, an upgraded e-commerce stack, and improved engagement tools such as SMS outreach and an influencer network that now reaches more than one million consumers.

The Company has widened its omnichannel footprint. Walmart.com added Charlotte’s Web’s new mushroom wellness gummies during the quarter, while strategic launches on Amazon, TikTok Shop, and Faire have dramatically broadened online reach. With additional categories and channels slated for launch in the coming quarters, the Company is well-positioned to meet consumers wherever they shop, diversifying revenue streams, and capturing incremental market share through improved digital discoverability.

Whole Foods Market Retail Distribution Launch
In a significant advancement of its retail expansion, the Company achieved a major milestone finalizing an agreement with Whole Foods Market to roll out products to more than 400 store locations nationwide. As part of this partnership, three isolate topical products will be available on shelves starting June 2025. This launch marks a significant step forward in making botanical wellness solutions more accessible to health-conscious consumers seeking trusted, plant-based alternatives.

Operational Efficiencies and Cost Management
Expense reductions initiated in 2024 continued to benefit operating performance, with year-over-year operating costs down 24.2%. Strengthening operations, Charlotte’s Web began preliminary in-house commercial production of gummies in Q2 2025, supporting gross margins and speed-to-market for new products. This production shift will enable the rapid development of new gummy blends.

“With successful expansion into new product categories, improving cash flow metrics, and enhanced operational efficiencies, Charlotte’s Web has a good start to 2025,” added Mr. Morachnick. “Our disciplined execution of strategic initiatives – from platform expansion to manufacturing optimization – positions us to build on this throughout 2025 and beyond, delivering value for shareholders and continued innovation for consumers.”

DeFloria Milestone
In the first quarter, DeFloria, Inc. – a joint entity established between Charlotte’s Web and Ajna BioSciences, with British American Tobacco as lead investor – received U.S. Food and Drug Administration (FDA) clearance to initiate Phase 2 clinical trials for its botanical pharmaceutical candidate, AJA001 Oral Solution, intended to treat irritability associated with autism spectrum disorder (“ASD”). AJA001 is formulated using Charlotte’s Web proprietary full-spectrum CBD extract derived from its patented cultivars. The FDA’s acceptance of DeFloria’s IND for AJA001 marks a significant milestone. In addition, Charlotte’s Web holds manufacturing rights for commercial supply when the drug is ultimately approved by the FDA, representing a potential opportunity that could be transformative for Charlotte’s Web over time.

On June 9, 2025, Charlotte’s Web and Ajna BioSciences will host an executive panel session at the Benzinga Cannabis Capital Conference in Chicago. As part of the panel discussion, Charlotte’s Web will showcase its partnership with DeFloria and AJA001’s clinical progress and therapeutic potential. For attendance information, contact IR@defloira.bio.

First Quarter 2025 Financial Review
The following table sets forth selected financial information for the periods indicated:

Three months ended

March 31,

U.S. $ millions, except per share data

2025

2024

Revenue

$

12.3

$

12.1

Cost of goods sold

$

6.1

$

5.2

Gross profit

6.2

6.9

Selling, general and administrative expenses

11.6

15.3

Operating loss

(5.4)

(8.4)

Change in fair value of financial instruments and other

(0.1)

(1.9)

Other income (expense) , net

(0.7)

0.6

Net loss

$

(6.2)

$

(9.7)

EPS basic and diluted

$

(0.04)

$

(0.06)

Adjusted EBITDA(1)

$

(2.8)

$

(3.9)

Assets:

Cash and cash equivalents

$

19.4

Total assets

$

108.0

Liabilities:

Long-term liabilities

$

68.5

Total liabilities

$

87.0

Quarterly revenue trend:

Q1

Q2

Q3

Q4

Q1

U.S. $ millions

2024

2024

2024

2024

2025

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

$ 12.3

Consolidated net revenue for the first quarter ended March 31, 2025, was $12.3 million, a year-over-year increase of 1.1% compared to $12.1 million in the first quarter of 2024. Propelled by the continued performance of the Company’s upgraded e-commerce platform, this represents the first period of year-over-year growth reported since Q2 2021 and builds upon a consecutive quarterly growth trend established in 2024. Introduced in mid-2024, the new platform has delivered measurable improvements in marketing effectiveness, customer engagement, and sales volumes. The Company also continues to generally outperform its peers in retail category benchmarks, reflecting the strength of its recent product innovations and the effectiveness of its strategic retail partnerships.

Gross profit in Q1 2025 was $6.2 million, or 50.8% of revenue, compared to gross profit of $6.9 million, or 57.0% of revenue, in Q1 2024. The prior year included temporary items favorable to gross margin. The Company models forward gross margin percentages to continue in the low 50s, supported partly by the transition to in-house production of gummies, followed by topical products over time.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $11.6 million, a 24.2% improvement from $15.3 million in Q1 2024. Stringent expense controls were implemented over the past year and remain a central focus in 2025.

Net loss for the first quarter of 2025 was $6.2 million, or ($0.04) per share basic and diluted, compared to a net loss of $9.7 million, or ($0.06) per share basic and diluted, for the first quarter of 2024.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported negative Adjusted EBITDA1 for the first quarter of 2025 of $2.8 million, a $1.1 million improvement compared to negative Adjusted EBITDA of $3.9 million in the first quarter of 2024.

Balance Sheet and Cash Flow
Net cash used for operations in the first quarter of 2025 was $2.8 million. The Company’s cash and working capital as of March 31, 2025, were $19.4 million and $25.5 million, respectively, compared to $22.6 million and $31.1 million as of December 31, 2024, respectively.

“With cash reserves exceeding $19 million and our anticipated cash flow improvements for this year, we are confident our balance sheet is sufficient to support growth for 2025 and beyond,” said Mrs. Lind.

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s consolidated financial statements and accompanying notes for the three month periods ended March 31, 2025, and 2024, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-Q filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and market leader in hemp extract wellness that includes Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information

Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance, and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions, expected future development, and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume and gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the Company’s ability to increase online traffic and demographic exposure through new products and marketing and omni-channel expansion; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory; launch of products in Whole Foods; continued product placement on various product channels; anticipated development of new products; the outcomes from DeFloria’s clinical trials, including commercial opportunities for Charlotte’s Web.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty, as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars, except share and per share amounts)

March 31,

December 31,

2025 (unaudited)

2024

ASSETS

Current assets:

Cash and cash equivalents

$ 19,357

$ 22,618

Accounts receivable, net

1,531

1,263

Inventories, net

18,916

18,907

Prepaid expenses and other current assets

4,201

4,194

Total current assets

44,005

46,982

Property and equipment, net

25,758

26,337

License and media rights

12,717

13,691

Operating lease right-of-use assets, net

12,404

12,876

Investment in unconsolidated entity

10,700

10,800

SBH purchase option and other derivative assets

970

1,075

Intangible assets, net

1,003

1,049

Other long-term assets

466

632

Total assets

$ 108,023

$ 113,442

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,943

$ 3,426

Accrued and other current liabilities

4,764

5,246

Lease obligations – current

1,844

2,055

License and media rights payable – current

7,937

5,209

Total current liabilities

18,488

15,936

Convertible debenture

44,753

43,631

Lease obligations

13,257

13,652

License and media rights payable

9,227

11,809

Derivative and other long-term liabilities

1,236

1,327

Total liabilities

86,961

86,355

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and
158,009,541 shares issued and outstanding as of March 31, 2025 and December
31, 2024

1

1

Additional paid-in capital

328,842

328,655

Accumulated deficit

(307,781)

(301,569)

Total shareholders’ equity

21,062

27,087

Total liabilities and shareholders’ equity

$ 108,023

$ 113,442

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except share and per share amounts)

Three Months Ended March 31,
(unaudited)

2025

2024

Revenue

$ 12,262

$ 12,124

Cost of goods sold

6,032

5,213

Gross profit

6,230

6,911

Selling, general, and administrative expenses

11,578

15,280

Operating loss

(5,348)

(8,369)

Change in fair value of financial instruments

(126)

(1,860)

Other income (expense), net

(738)

611

Loss before provision for income taxes

$ (6,212)

$ (9,618)

Income tax expense

—

(16)

Net loss

$ (6,212)

$ (9,634)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.04)

$ (0.06)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

Common shares issued upon vesting of restricted share units,
net of withholding

—

—

—

—

—

Share-based compensation

—

—

187

—

187

Net loss

—

(6,212)

(6,212)

Balance—March 31, 2025

158,009,541

$ 1

$ 328,842

$ (307,781)

$ 21,062

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units,
net of withholding

2,895,489

—

(98)

—

(98)

Share-based compensation

—

842

—

842

Net loss

—

(9,634)

(9,634)

Balance—March 31, 2024

157,227,855

$ 1

$ 328,024

$ (281,357)

$ 46,668

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Three Months Ended March 31,
(unaudited)

2025

2024

Cash flows from operating activities:

Net loss

$ (6,212)

$ (9,634)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

2,449

2,493

Change in fair value of financial instruments

126

1,860

Convertible debenture and other accrued interest

868

1,015

Changes in right-of-use assets

473

443

Share-based compensation

187

842

Other

126

(956)

Changes in operating assets and liabilities:

Accounts receivable, net

(394)

98

Inventories, net

19

(1,026)

Prepaid expenses and other current assets

28

150

License and media rights

—

(2,500)

Operating lease obligations

(605)

(551)

Accounts payable, accrued and other liabilities

71

663

Other operating assets and liabilities, net

96

(76)

Net cash used in operating activities

(2,768)

(7,179)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(521)

(2,060)

Proceeds from sale of assets

28

27

Net cash used in investing activities

(493)

(2,033)

Cash flows from financing activities:

Other financing activities

—

(98)

Net cash used in financing activities

—

(98)

Net decrease in cash and cash equivalents

(3,261)

(9,310)

Cash and cash equivalents —beginning of period

22,618

47,820

Cash and cash equivalents —end of period

$ 19,357

$ 38,510

Non-cash activities:

Non-cash purchase of property and equipment and intangible assets

$ (83)

$ (374)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financial measures do not have a standardized meaning prescribed under U.S. GAAP and, therefore, may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

Adjusted EBITDA for the three months ended March 31, 2025, and 2024 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended
March 31,
(unaudited)

U.S. $ Thousands

2025

2024

Net loss

$

(6,212)

$

(9,618)

Depreciation of property and equipment and amortization of intangibles

2,449

2,493

Interest expense

685

487

Income tax expense

16

EBITDA

(3,078)

(6,622)

Share-based compensation

187

842

Mark-to-market financial instruments

126

1,860

Adjusted EBITDA

$

(2,765)

$

(3,920)

SOURCE Charlotte’s Web Holdings, Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/14/c3289.html

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports Year-Over-Year Growth For Q1 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Investing in marijuana stocks amid market volatility needs a strategic approach, balancing potential growth with inherent risks. Currently, the U.S. cannabis industry is experiencing a period of both challenge and opportunity. While the sector continues to grow with legal cannabis sales breaking the billion mark, investors face headwinds such as regulatory uncertainties, and price reduction.

Not to mention, no federal reform and limited access to standard banking services. Nevertheless, these battles have led to more reasonable valuations, presenting potential entry points for long-term investors. What this means is that with a sector this low in price, finding top marijuana stocks to buy is easier and more affordable. The long-term approach is where most see the best odds for better returns.

The anticipated federal rescheduling of cannabis and the possible passage of the SAFE Banking Act could be significant catalysts. These changes could potentially improve profitability and attract institutional funds. Moreover, the industry’s resilience is evident in its support of over 440,000 full-time jobs and its expansion across 41 states. While risks remain, particularly for smaller operators, the evolving regulatory landscape and growing consumer acceptance suggest that, for those willing to navigate the complexities, now could be an opportune time to consider investments in cannabis stocks.

Marijuana Stocks To Watch Now

1. Green Thumb Industries Inc. (OTC:GTBIF)
2. Planet 13 Holdings Inc.(OTC:PLNH)
3. Curaleaf Holdings, Inc. (OTC:CURLF)

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States.

It operates through two segments, Retail and Consumer Packaged Goods. On May 7th, the company reported its first quarter 2025 earnings.

Highlights And Key Mentions 2025

• Revenue of $280 million, an increase of 1% over the prior year period.
• Cash flow from operations of $74 million.
• Cash at quarter end totaled $211 million.
• GAAP net income of $8 million or $0.04 per basic and diluted share.
• Adjusted EBITDA of $85 million or 31% of revenue.

[Read More] Top 3 Marijuana Stocks For Better Investing 2025

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. In recent news, the company has announced it will report its Q1 2025 earnings on May 14th.

Planet 13 will host a conference call on May 14th, 2025, to discuss its first-quarter financial results and provide investors with key business highlights, strategy, and outlook. The call will be chaired by Bob Groesbeck, Co-CEO, Larry Scheffler, Co-CEO, and Dennis Logan, CFO.

[Read More] 2 Top Marijuana Stocks To Invest In For Long-Term Trading

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. In more recent news, the company has initiated a collaboration with Jupiter Research LLC, a subsidiary of TILT Holdings Inc. 

So Curaleaf has secured regulatory approval for the first handheld liquid inhalation device designed for precise medical cannabis administration. This EU medical device certification (Regulation (EU) 2017/745) paves the way for improved patient options and a new era of innovation in medical cannabis delivery.

The post 3 Marijuana Stocks For Long-Term Investing 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in collaboration with Jupiter Research LLC, a subsidiary of TILT Holdings Inc. (“TILT”) (Cboe CA: TILT) (OTCPK: TLLTF), has secured regulatory approval for the first handheld liquid inhalation device designed for precise medical cannabis administration. This EU medical device certification (Regulation (EU) 2017/745) paves the way for improved patient options and a new era of innovation in medical cannabis delivery.

The liquid inhalation device is now certified as a Class IIa medical device, meeting rigorous European regulatory standards. The device includes a magnetic snap-in cartridge and a rechargeable power supply, engineered to provide a consistent and controlled cannabinoid delivery. A comprehensive technical file and full EU Declaration of Conformity were assessed and approved by a recognised EU Notified Body, validating the device’s quality, safety, and clinical robustness.

EU certification supports deployment in multiple global markets and once commercialised, will enable healthcare professionals to recommend the device offered by Curaleaf International in countries including European countries, the UK, Canada, and regions across Australasia.

Boris Jordan, Chairman and CEO of Curaleaf, commented on this achievement:
“Achieving EU medical certification is more than a regulatory milestone—it’s a signal that medical cannabis innovation is moving into the mainstream of global healthcare. We’re proud to offer a device that meets the highest standards of safety and quality, and we look forward to supporting patients and healthcare providers across Europe and beyond with a new, accurate and discrete option for treatment.”

Echoing this sentiment, TILT’s Chief Executive Officer Tim Conder, added:
“Partnering with Curaleaf International on this project has been a natural extension of our long-standing partnership in the US. By delivering industry-leading, user-friendly solutions, our collaboration exemplifies how technology can revolutionise healthcare. Achieving EU medical certification on IP developed by our subsidiary Jupiter Research, validates the robustness of our engineering and R&D functions and sets a new benchmark for the industry.”

This development reinforces Curaleaf International’s role at the forefront of advancing access to legal, high-quality cannabis treatments across Europe and other international markets.

About Curaleaf International
Curaleaf International is shaping the future of cannabis through its commitment to research and product excellence. Powered by a strong presence at all stages of the supply chain, its unique distribution network throughout Europe, Canada and Australasia brings together pioneering research with cutting-edge cultivation, extraction, and production. Amidst a rapid growth trajectory, the emphasis on quality and expertise aims to ensure the delivery of safe and legal cannabis.

Curaleaf International’s network includes a clinic, pharmacy, and laboratory in the UK; cultivation and EU-GMP processing facilities in Portugal; an EU-GMP processing, quality assurance and research site in Spain; Four20 Pharma wholesaler and distributor in Germany; a Polish wholesaler and clinic; and the EU-GMP producer Northern Green Canada.

Curaleaf International is part of Curaleaf Holdings, Inc., a leading international producer and distributor of consumer cannabis products.

About TILT and Jupiter Research
TILT Holdings manages a diverse portfolio of companies in the cannabis industry, encompassing technology, hardware, cultivation, and production. Its core business, Jupiter Research LLC, is a wholly owned subsidiary and a global distribution leader in the vaporization segment. Jupiter is dedicated to hardware design, research, development, and distribution to support cannabis brands and retailers across the United States, Canada, South America, and the European Union. Additionally, TILT is a multi-state operator, with cultivation and production facilities in three states under the Commonwealth Alternative Care and Standard Farms brands. For more information, visit www.tiltholdings.com.

Media Contact:

Curaleaf International:
Beth Sweet-Escott
Head of Communications, Curaleaf International
media@curaleafint.com

TILT:
Lynn Ricci
VP of Investor Relations & Corporate Communications, TILT Holdings Inc.
lricci@tiltholdings.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-international-in-partnership-with-jupiter-research-secures-eu-medical-device-certification-for-europes-first-handheld-liquid-inhalation-device-302451697.html

SOURCE Curaleaf International

The post Curaleaf Holdings, Inc (CURLF) Secures EU Medical Device Certification for Europe’s First Handheld Liquid Inhalation Device appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Let us take a better look at the progress of the cannabis industry and all that has been done. Since 2018, legal cannabis has been on the move, with every setback being a preparation for a major comeback. Legal operators in the US have been under fire since day one of heading to market. Many regulations and restrictions make things tough, especially for the non-MSO or family-run farms.

But even with obstacles in the way, many companies have been able to overcome this and stay the course. Currently, legal cannabis is in a transitional period, with consumers wanting more options besides just plain flower. This means drinks, foods, and vaping as a substitute for the classic joint. Much of these consumer demands have been met, and companies seem to be doing well. Even though this has not led to any momentum for the cannabis niche in the public sector.

Most marijuana stocks are still down as the market has, for some time, been in a volatile downtrend. However, with legal operators doing well as a business, investors see the long game as the potential to see sizable returns. So, with this, now could be another chance to find top marijuana stocks to buy while share prices are low. Make sure always to do your research and have a trading plan. A good strategy to follow that can help with your investing. Below are some marijuana stocks to watch as more companies are preparing to report earnings.

Top Marijuana Stocks To Watch Today 2025

1. GrowGeneration Corp. (OTC:GRWG)
2. Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)
3. The Scotts Miracle-Gro Company (NYSE:SMG)

GrowGeneration Corp.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It operates through two segments, Cultivation and Gardening, and Storage Solutions.

In recent news, the company will be reporting its Q1 2025 earnings. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. With this, GrowGen has scheduled a conference call for May 8th, 2025.

Hydrofarm Holdings Group, Inc.

Hydrofarm Holdings Group, Inc., together with its subsidiaries, manufactures and distributes hydroponics equipment and supplies for controlled environment agriculture (CEA) in the United States and Canada.

In more recent news, the company will be announcing its first quarter 2025 results on May 13th, 2025. A press release containing first quarter 2025 results will be issued before market open that same day.

[Read More] Investing in Green: Top U.S. Marijuana Stocks for May 2025

The Scotts Miracle-Gro Company

The Scotts Miracle-Gro Company, together with its subsidiaries, engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. 

On April 30th, the company reported its Q1 2025 financial results. During this time, the company saw an improvement in its gross margin, which drives EBITDA growth.

[Read More] 2 Pot Stocks For Investors Looking To Enter The Cannabis Industry

Words From The Company

“We have made substantial progress in the key financial metrics that support our full-year guidance,” said Jim Hagedorn, chairman and CEO.”

The post Here Is How The Cannabis Industry Impacts The Public Sector appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Here is what you should know about the potential upside to investing in marijuana stocks today. But first, let’s get a perspective on the past to understand how the market has changed. Back in 2018, to the start of the pandemic, most cannabis stocks saw a big wave of consistent trading. Even when there was a pullback, it was quick to see a bounce that at some points reached higher highs for that period.

This was due to how new and exciting the start of the legal cannabis movement was. State after state was working to pass bills that would ultimately lead to what we are seeing now. More than half of the United States has already legalized cannabis in some form. This has built a growing market that has created large amounts of revenue. Now with the fight to get better and more advantageous reform measures passed is key.

The pause and uncertainty about when federal reform will pass are increasing the level of volatility. Along with the politics that come with it, and fear about what our current President may do. Now, the future is where many see the potential as the cannabis industry continues to thrive. This tells investors that even with the sector down, legal operators are still standing strong and profitable. So if you can weather the volatile storm, trading could become more profitable as the industry further evolves. Below are several marijuana stocks to watch with the potential to be big gainers in 2025.

Top Marijuana To Watch Today

1. Green Thumb Industries Inc. (OTC:GTBIF)
2. Trulieve Cannabis Corp. (OTC:TCNNF)
3. Planet 13 Holdings Inc. (OTC:PLNH)

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult-use in the United States. In recent news, the company announced the opening of a new RISE dispensary.

This new location is in Ocala, Florida, and makes for the company’s 104th retail location in the nation and 22nd location in the state.

Words From The Company

“We are thrilled to open our first RISE Dispensary in Ocala, where our cultivation/production facility has already brought close to 100 jobs to the community. We are honored to create more job opportunities through the opening of RISE Dispensary Ocala while also bringing well-being to more Florida patients,” said Green Thumb President Anthony Georgiadis. ”

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. Back in April, the company announced it would be reporting its Q1 2025 earnings on May 7th.

This will also be followed up with an earnings conference call. Chairman, Founder, and Chief Executive Officer Kim Rivers and Interim Chief Financial Officer Ryan Blust will participate in the call to review Trulieve’s financial and operating results.

[Read More] High Potential: Canadian Cannabis Stocks Making Waves in May 2025

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

On April 30th, the company announced it has opened its 33rd Florida dispensary. The new store is in Edgewater, just a bit south of Daytona Beach.

[Read More] 3 Marijuana Stocks For The Long Term Investing

Words From The CEO

“We’re proud to bring the Planet 13 experience to Edgewater as we continue our growth across Florida,” said Bob Groesbeck, Co-CEO of Planet 13. “Situated on U.S. Highway 1, a major retail corridor, this location offers excellent accessibility for patients.”

The post Top Marijuana Stocks With Upside Potential In The Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the case and things have changed drastically. Still, the way companies are keeping up with. Market demand profits and revenue are steadily rising. However, this success has played very little in how most marijuana stocks trade.

But continued success during a complicated time gives hope for the future. Right now there is more concern about what will happen with Donald Trump in office. Yet nothing major has truly happened that has slowed down or halted anyone’s flower or edible brands. Now with tariffs in place for China, it could impact certain packaging and parts needed for vaporizing. Especially companies with portable cannabis vape pens as part of their main products in medical and recreational markets.

However, this has not stopped the show for most companies as earnings are still being released which are showing strong results for some. What this does for cannabis investors is show stability in a trying time. Also, it gives a better outlook on the upside down the road. The long game is what most investors are aiming for when it comes to marijuana stocks buy.

Top Marijuana Stocks In Today’s Market

1. Aurora Cannabis Inc. (NASDAQ:ACB)
2. Cronos Group Inc. (NASDAQ:CRON)
3. SNDL Inc. (NASDAQ:SNDL)

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis derivative products in Canada and internationally.

It operates through two segments, Canadian Cannabis and Plant Propagation. In recent news, the company announced it has completed its multimillion-dollar investment of a B.C. manufacturing facility. The site has been renamed to Aurora Alpine – a testament to the site reaching its highest potential.

Word From The Company

“Over the last three years, the investments we’ve made into this facility have resulted in doubling the yield and potency, reaching a record 33.7%,” says Alex Miller, Executive Vice President of Operations and Supply Chain at Aurora.”

Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

On April 28th the company will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast.

[Read More] The Best Marijuana To Make Potential Profits In 2025

SNDL Inc.

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through four segments:

Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. Recently the company reported its Q1 2025 financial earnings.

[Read More] Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist

Highlights And Keymentions

• Net revenue: In the first quarter of 2025, net revenue totaled $204.9 million, reflecting a growth rate of +3.6%.
• Gross profit: Gross profit for the first quarter of 2025 reached $56.6 million, marking a strong growth of +12.4%
• Gross margin (1): The gross margin in the first quarter of 2025 was 27.6%, setting a new record for the company.
• Operating loss: Operating loss for the first quarter of 2025 amounted to $(12.1) million.

The post 3 Marijuana Stocks For The Long Term Investing appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..